CD4 + T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashion
We would like to make two corrections to our previously published paper (Cancer Immunol Immunother 40: 1-9, above title): 1. The anti-breast cancer activity of TIL 1288 in Fig. 1 (p 4) is completely specific for the autologous tumor based on repeated assays of TNF-~-secretion (see new In Fig. 3 (p 5) of our published paper, the value 895/pg/ ml was erroneously transcribed as 1895 pg/ml. Thus, there is no convincing data that the reactivity of TIL from patient 1392 is tumor specific. 
